{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T14:50:19Z","timestamp":1791989419676,"version":"4.4.0"},"reference-count":47,"publisher":"Elsevier BV","issue":"2-3","license":[{"start":{"date-parts":[[2006,9,1]],"date-time":"2006-09-01T00:00:00Z","timestamp":1157068800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Antiviral Research"],"published-print":{"date-parts":[[2006,9]]},"DOI":"10.1016\/j.antiviral.2006.03.011","type":"journal-article","created":{"date-parts":[[2006,4,19]],"date-time":"2006-04-19T17:42:46Z","timestamp":1145468566000},"page":"391-396","source":"Crossref","is-referenced-by-count":104,"title":["Rhinovirus chemotherapy"],"prefix":"10.1016","volume":"71","author":[{"given":"Amy K.","family":"Patick","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.antiviral.2006.03.011_bib1","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1128\/AAC.33.4.522","article-title":"Suppression of colds in human volunteers challenged with rhinovirus by a new synthetic drug (R61837)","volume":"33","author":"Al-Nakib","year":"1989","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2006.03.011_bib2","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1128\/AAC.36.1.100","article-title":"In vitro activity of pirodavir (R77975), a substituted phenoxy-pyridazinamine with broad-spectrum antipicornaviral activity","volume":"36","author":"Andries","year":"1992","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2006.03.011_bib3","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1128\/JVI.64.3.1117-1123.1990","article-title":"Two groups of rhinoviruses revealed by a panel of antiviral compounds present sequence divergence and differential pathogenicity","volume":"64","author":"Andries","year":"1990","journal-title":"J. Virol."},{"issue":"5","key":"10.1016\/j.antiviral.2006.03.011_bib4","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1378\/chest.123.5.1664","article-title":"Diagnosis and treatment of rhinovirus respiratory infections","volume":"123","author":"Anzueto","year":"2003","journal-title":"Chest"},{"issue":"2","key":"10.1016\/j.antiviral.2006.03.011_bib5","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1128\/AAC.49.2.619-626.2005","article-title":"Conservation of amino acids in human rhinovirus 3C protease correlates with broad-spectrum antiviral activity of rupintrivir, a novel human rhinovirus 3C protease inhibitor","volume":"49","author":"Binford","year":"2005","journal-title":"Antimicrob. Agents Chemother."},{"issue":"2","key":"10.1016\/j.antiviral.2006.03.011_bib6","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/0163-7258(94)90040-X","article-title":"Picornavirus inhibitors","volume":"64","author":"Carrasco","year":"1994","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.antiviral.2006.03.011_bib7","series-title":"Virology","first-page":"607","article-title":"Rhinoviruses","author":"Couch","year":"1990"},{"issue":"12","key":"10.1016\/j.antiviral.2006.03.011_bib8","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1021\/jm00150a025","article-title":"[[(4,5-Dihydro-2-oxazolyl)phenoxy]alkyl]isoxazoles. Inhibitors of picornavirus uncoating","volume":"28","author":"Diana","year":"1985","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.antiviral.2006.03.011_bib9","doi-asserted-by":"crossref","first-page":"4572","DOI":"10.1021\/jm030166l","article-title":"Structure-based design, synthesis, and biological evaluation of irreversible human rhinovirus 3C protease inhibitors. 8. Pharmacological optimization of orally bioavailable 2-pyridone-containing peptidomimetics","volume":"46","author":"Dragovich","year":"2003","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.antiviral.2006.03.011_bib10","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1021\/jm9805384","article-title":"Structure-based design, synthesis, and biological evaluation of irreversible human rhinovirus 3C protease inhibitors. 4. Incorporation of P1 lactam moieties as l-glutamine replacements","volume":"42","author":"Dragovich","year":"1999","journal-title":"J. Med. Chem."},{"issue":"12","key":"10.1016\/j.antiviral.2006.03.011_bib11","first-page":"1722","article-title":"Safety and efficacy evaluation of pleconaril for treatment of the common cold","volume":"15","author":"Fleischer","year":"2003","journal-title":"Clin. Infect. Dis."},{"issue":"2\u20133","key":"10.1016\/j.antiviral.2006.03.011_bib12","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/0166-3542(95)00935-3","article-title":"The influence of signal variation, bias, noise and effect size on statistical significance in treatment studies of the common cold","volume":"29","author":"Gwaltney","year":"1996","journal-title":"Antivir. Res."},{"issue":"112 Suppl. 6A","key":"10.1016\/j.antiviral.2006.03.011_bib13","doi-asserted-by":"crossref","first-page":"33S","DOI":"10.1016\/S0002-9343(01)01062-2","article-title":"Viral respiratory infection therapy: historical perspectives and current trials","volume":"22","author":"Gwaltney","year":"2002","journal-title":"Am. J. Med."},{"key":"10.1016\/j.antiviral.2006.03.011_bib14","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1086\/341455","article-title":"Combined antiviral-antimediator treatment for the common cold","volume":"186","author":"Gwaltney","year":"2002","journal-title":"J. Infect. Dis."},{"issue":"6","key":"10.1016\/j.antiviral.2006.03.011_bib15","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1093\/clinids\/23.6.1287","article-title":"Incubation periods of experimental rhinovirus infection and illness","volume":"23","author":"Harris","year":"1996","journal-title":"Clin. Infect. Dis."},{"issue":"12","key":"10.1016\/j.antiviral.2006.03.011_bib16","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1086\/375069","article-title":"Pleconaril respiratory infection study group. Efficacy and safety of oral pleconaril for treatment of colds due to picornaviruses in adults: results of two double-blind, randomized, placebo-controlled trials","volume":"36","author":"Hayden","year":"2003","journal-title":"Clin. Infect. Dis."},{"issue":"2","key":"10.1016\/j.antiviral.2006.03.011_bib17","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1056\/NEJM198601093140202","article-title":"Prevention of natural colds by contact prophylaxis with intranasal alpha 2-interferon","volume":"314","author":"Hayden","year":"1986","journal-title":"N. Engl. J. Med."},{"issue":"4","key":"10.1016\/j.antiviral.2006.03.011_bib18","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1128\/AAC.36.4.727","article-title":"Safety and efficacy of intranasal pirodavir (R77975) in experimental rhinovirus infection","volume":"36","author":"Hayden","year":"1992","journal-title":"Antimicrob. Agents Chemother."},{"issue":"1","key":"10.1016\/j.antiviral.2006.03.011_bib19","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1177\/135965350200700107","article-title":"Oral pleconaril treatment of picornavirus-associated viral respiratory illness in adults: efficacy and tolerability in phase II clinical trials","volume":"7","author":"Hayden","year":"2002","journal-title":"Antivir. Ther."},{"key":"10.1016\/j.antiviral.2006.03.011_bib20","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1128\/AAC.32.2.224","article-title":"Intranasal recombinant alfa-2b interferon treatment of naturally occurring common colds","volume":"32","author":"Hayden","year":"1988","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2006.03.011_bib21","doi-asserted-by":"crossref","first-page":"3907","DOI":"10.1128\/AAC.47.12.3907-3916.2003","article-title":"Phase II, randomized, double-blind, placebo-controlled studies of rupintrivir nasal spray 2-percent suspension for prevention and treatment of experimentally induced rhinovirus colds in healthy volunteers","volume":"47","author":"Hayden","year":"2003","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2006.03.011_bib22","first-page":"CD002743","article-title":"Antivirals for the common cold","volume":"3","author":"Jefferson","year":"2001","journal-title":"Cochrane Database Syst. Rev."},{"issue":"3","key":"10.1016\/j.antiviral.2006.03.011_bib23","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0166-3542(00)00106-6","article-title":"In vitro activity of pleconaril and AG-7088 against selected serotypes and clinical isolates of human rhinoviruses","volume":"47","author":"Kaiser","year":"2000","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2006.03.011_bib24","doi-asserted-by":"crossref","first-page":"11000","DOI":"10.1073\/pnas.96.20.11000","article-title":"Structure-assisted design of mechanism based irreversible inhibitors of human rhinovirus 3C protease with potent antiviral activity against multiple rhinovirus serotypes","volume":"96","author":"Matthews","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.antiviral.2006.03.011_bib25","series-title":"Learning from SARS: Preparing for the Next Disease Outbreak","first-page":"186","article-title":"In vitro antiviral activity of human rhinovirus 3C protease inhibitors against the SARS coronavirus","author":"Matthews","year":"2004"},{"key":"10.1016\/j.antiviral.2006.03.011_bib26","first-page":"A72","article-title":"PCR amplification and determination of the RNA sequences for the P3 coding region of human rhinoviral serotypes","volume":"37","author":"Meador","year":"1998","journal-title":"Antivir. Res."},{"issue":"12","key":"10.1016\/j.antiviral.2006.03.011_bib27","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1016\/S0149-2918(02)80093-5","article-title":"The seasonality of rhinovirus infections and its implications for clinical recognition","volume":"24","author":"Monto","year":"2002","journal-title":"Clin. Ther."},{"issue":"1","key":"10.1016\/j.antiviral.2006.03.011_bib28","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1093\/infdis\/157.1.133","article-title":"Kinins are generated during experimental rhinovirus colds","volume":"157","author":"Naclerio","year":"1988","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.antiviral.2006.03.011_bib29","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S1386-6532(01)00150-0","article-title":"Rapid multiserotype detection of human rhinoviruses on optically coated silicon surfaces","volume":"21","author":"Ostroff","year":"2001","journal-title":"J. Clin. Virol."},{"issue":"6","key":"10.1016\/j.antiviral.2006.03.011_bib30","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1128\/AAC.27.6.883","article-title":"In vitro activity of WIN 51711, a new broad-spectrum antipicornavirus drug","volume":"27","author":"Otto","year":"1985","journal-title":"Antimicrob. Agents Chemother."},{"issue":"6","key":"10.1016\/j.antiviral.2006.03.011_bib31","doi-asserted-by":"crossref","first-page":"2267","DOI":"10.1128\/AAC.49.6.2267-2275.2005","article-title":"In vitro antiviral activity and single-dose pharmacokinetics in humans of a Novel, Orally Bioavailable Inhibitor of Human Rhinovirus 3C Protease","volume":"49","author":"Patick","year":"2005","journal-title":"Antimicrob. Agents Chemother."},{"issue":"4","key":"10.1016\/j.antiviral.2006.03.011_bib32","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1128\/CMR.11.4.614","article-title":"Protease inhibitors as antiviral agents","volume":"11","author":"Patick","year":"1998","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.antiviral.2006.03.011_bib33","doi-asserted-by":"crossref","first-page":"2444","DOI":"10.1128\/AAC.43.10.2444","article-title":"Antiviral activity of AG7088, a potent inhibitor of human rhinovirus 3C protease","volume":"43","author":"Patick","year":"1999","journal-title":"Antimicrob. Agents Chemother."},{"issue":"11","key":"10.1016\/j.antiviral.2006.03.011_bib34","doi-asserted-by":"crossref","first-page":"4492","DOI":"10.1128\/AAC.49.11.4492-4499.2005","article-title":"Relationship of pleconaril susceptibility and clinical outcomes in treatment of common colds caused by rhinoviruses","volume":"49","author":"Pevear","year":"2005","journal-title":"Antimicrob. Agents Chemother."},{"issue":"9","key":"10.1016\/j.antiviral.2006.03.011_bib35","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1128\/AAC.43.9.2109","article-title":"Activity of pleconaril against enteroviruses","volume":"43","author":"Pevear","year":"1999","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2006.03.011_bib36","first-page":"50","article-title":"What's new with common colds? Pathogenesis and diagnosis","volume":"15","author":"Pitkaranta","year":"1998","journal-title":"Infect. Med."},{"key":"10.1016\/j.antiviral.2006.03.011_bib37","doi-asserted-by":"crossref","first-page":"49","DOI":"10.2500\/105065895781874114","article-title":"Symptom expression in natural and experimental rhinovirus colds","volume":"9","author":"Rao","year":"1995","journal-title":"Am. J. Rhinol."},{"issue":"6033","key":"10.1016\/j.antiviral.2006.03.011_bib38","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/317145a0","article-title":"Structure of a human common cold virus and functional relationship to other picornaviruses","volume":"317","author":"Rossmann","year":"1985","journal-title":"Nature"},{"key":"10.1016\/j.antiviral.2006.03.011_bib39","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0166-3542(01)00206-6","article-title":"Treatment of picornavirus infections","volume":"53","author":"Rotbart","year":"2002","journal-title":"Antivir. Res."},{"issue":"1","key":"10.1016\/j.antiviral.2006.03.011_bib40","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1086\/315176","article-title":"Clinical activity of pleconaril in an experimentally induced coxsackievirus A21 respiratory infection","volume":"181","author":"Schiff","year":"2000","journal-title":"J. Infect. Dis."},{"issue":"4","key":"10.1016\/j.antiviral.2006.03.011_bib41","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1002\/med.10067","article-title":"Selective human enterovirus and rhinovirus inhibitors: an overview of capsid-binding and protease-inhibiting molecules","volume":"24","author":"Shih","year":"2004","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.antiviral.2006.03.011_bib42","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1128\/AAC.32.4.409","article-title":"Chemotherapy of rhinovirus colds","volume":"32","author":"Sperber","year":"1988","journal-title":"Antimicrob. Agents Chemother."},{"issue":"1","key":"10.1016\/j.antiviral.2006.03.011_bib43","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0166-3542(00)00135-2","article-title":"The treatment of rhinovirus infections: progress and potential","volume":"49","author":"Turner","year":"2001","journal-title":"Antivir. Res."},{"issue":"2","key":"10.1016\/j.antiviral.2006.03.011_bib44","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1128\/AAC.37.2.297","article-title":"Efficacy of oral WIN 54954 for prophylaxis of experimental rhinovirus infection","volume":"37","author":"Turner","year":"1993","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2006.03.011_bib45","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1001\/jama.281.19.1797","article-title":"Efficacy of tremacamra, a soluble intercellular adhesion molecule 1, for experimental rhinovirus infection: a randomized clinical trial","volume":"281","author":"Turner","year":"1999","journal-title":"JAMA"},{"key":"10.1016\/j.antiviral.2006.03.011_bib46","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1086\/513922","article-title":"Association between interleukin-8 concentration in nasal secretions and severity of symptoms of experimental rhinovirus colds","volume":"26","author":"Turner","year":"1998","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.antiviral.2006.03.011_bib47","doi-asserted-by":"crossref","first-page":"9","DOI":"10.3109\/00016488409128535","article-title":"Sites of virus recovery and antigen detection in epithelial cells during experimental rhinovirus infection","volume":"413","author":"Turner","year":"1984","journal-title":"Acta Otolaryngol. Suppl."}],"container-title":["Antiviral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354206000908?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354206000908?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,7]],"date-time":"2023-05-07T04:07:28Z","timestamp":1683432448000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166354206000908"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,9]]},"references-count":47,"journal-issue":{"issue":"2-3","published-print":{"date-parts":[[2006,9]]}},"alternative-id":["S0166354206000908"],"URL":"https:\/\/doi.org\/10.1016\/j.antiviral.2006.03.011","relation":{},"ISSN":["0166-3542"],"issn-type":[{"value":"0166-3542","type":"print"}],"subject":[],"published":{"date-parts":[[2006,9]]}}}